Cambrian Bio
StartupUS1 field
Where it works
| Technology | ||
|---|---|---|
| Longevity biotechClinical-stage company developing drugs that target metabolic pathways that decline with age, such as AMPK and mTOR. | Clinical-stage company developing drugs that target metabolic pathways that decline with age, such as AMPK and mTOR. | cambrianbio.com |
About
- Source
- cambrianbio.com (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
| Date | Change | ||
|---|---|---|---|
| Sep 25, 2026 | Cambrian BioCompany in Longevity biotech: Joined a field, Clinical-stage company developing drugs that target metabolic pathways that decline with age, such as AMPK and mTOR. | seed | cambrianbio.com |
| Sep 25, 2026 | Cambrian BioCompany: Added | seed | cambrianbio.com |